SABCS Spin-Off | 06 - Hudis

Breast Cancer Update

English - March 16, 2007 20:55 - 15 minutes - 8.71 MB - ★★★★ - 57 ratings
Science Health & Fitness Medicine breastcancer breast cancer oncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: SABCS Spin-Off | 06 - Dixon

Next Episode: SABCS Spin-Off | 06 - Buzdar

Outside a protocol setting, dose-dense AC ->paclitaxel, administered every two weeks with growth factors, with trastuzumab during and following the paclitaxel, provides the best potential risk/benefit profile for women with HER2-positive, node-positive disease.